Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland-Reference-Cited by-同舟云学术

Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland

Published:2023-08 Issue:1 Volume:26 Page:963-972
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Rivolo Simone¹^ORCID,Loftus Jane²^ORCID,Peter Balazs³^ORCID,Fahey Marion⁴,Kongnakorn Thitima⁵

Affiliation:

1. Evidera, Inc. Milan, Italy

2. Value & Evidence, Pfizer, Walton Oaks, UK

3. Evidera, Inc. Budapest, Hungary

4. Pfizer Healthcare, Ireland

5. Evidera, Bangkok, Thailand

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2228167

Reference71 articles.

1. National Institute for Health and Care Excellence (NICE). Human growth hormone (somatropin) for the treatment of growth failure in children. Technology appraisal guidance [TA188]. 2010 [cited 2021 May 26]. Available from: https://www.nice.org.uk/guidance/ta188

2. Utah Growth Study: Growth standards and the prevalence of growth hormone deficiency

3. Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001

4. Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review

5. Possible effects of an early diagnosis and treatment in patients with growth hormone deficiency: the state of art

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors' response to a critical appraisal on “Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency”;Journal of Medical Economics;2024-09-05

2. Critical appraisal on “Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency”;Journal of Medical Economics;2024-07-08

3. I LAGH (ormoni della crescita long-acting): cosa sono e a chi proporli?;Medico e Bambino;2024-06-24

4. Cost-effectiveness of somatrogon in the Spanish pediatric population with growth hormone deficiency;Expert Review of Pharmacoeconomics & Outcomes Research;2023-09-24